This country profile provides an overview of the Democratic Republic of the Congo’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
80%
Blinding trachoma
57%
Intestinal worms
86%
Bilharzia
68%
River blindness
81%
52.26 million
people received treatment in the Democratic Republic of the Congo in 2019
1.06 million
people did not receive treatment in the Democratic Republic of the Congo in 2019
Elephantiasis
Treatment coverage increased from 77% in 2018 to 80% in 2019.
People needing treatment
46.05m
People receiving treatment
36.95m
Blinding trachoma
Treatment coverage increased from 19% in 2018 to 57% in 2019.
People needing treatment
12.53m
People receiving treatment
7.14m
Intestinal worms
Treatment coverage increased from 52% in 2018 to 86% in 2019.
Pre-sch and school-aged children needing treatment
29.64m
Pre-school and school-aged children receiving treatment
25.58m
Bilharzia
Treatment coverage decreased from 69% in 2018 to 68% in 2019.
School-aged children needing treatment
11.19m
School-aged children receiving treatment
7.56m
River blindness
Treatment coverage increased from 79% in 2018 to 81% in 2019.
People needing treatment
49.33m
People receiving treatment
39.81m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Democratic Republic of the Congo.